000			01945 a2200493 4500
005			20250518043845.0
264		0	_c20200601
008			202006s 0 0 eng d
022			_a1879-0852
024	7		_a10.1016/j.ejca.2019.05.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aObermannova, Radka
245	0	0	_aHigh prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _c07 2019
300			_a107-113 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xblood
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCapecitabine _xtherapeutic use
650	0	4	_aCetuximab _xtherapeutic use
650	0	4	_aCisplatin _xtherapeutic use
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrevalence
650	0	4	_aPrognosis
650	0	4	_aStomach Neoplasms _xblood
650	0	4	_aTreatment Outcome
650	0	4	_aVitamin D _xblood
650	0	4	_aVitamin D Deficiency _xepidemiology
700	1		_aValik, Dalibor
700	1		_aHasenclever, Dirk
700	1		_aZdrazilova-Dubska, Lenka
700	1		_aHacker, Ulrich
700	1		_aDemlova, Regina
700	1		_aSelingerova, Iveta
700	1		_aLordick, Florian
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 116 _gp. 107-113
856	4	0	_uhttps://doi.org/10.1016/j.ejca.2019.05.011 _zAvailable from publisher's website
999			_c29794666 _d29794666